It has raised funds from Bono, The Edge and Salesforce CEO Marc Benioff, and secured a line of credit from the European Investment Bank. However, amid mounting losses, auditors for Nuritas expressed “significant doubt on the company’s ability to continue as a going concern” in the 2020 accounts for the biotech company. Since then the company has bounced back. In November, it closed a massive $45 million funding round to help accelerate its global expansion. The investment, which brought total funding to $75 million, was led by Chicago-based Cleveland Avenue and included backing from Grosvenor’s Wheatsheaf Group, the European Circular…

Join The Currency

INTRODUCTORY OFFER: Full annual membership for just €200.

Don’t miss out on what is going on with our daily unique stories from our team of skilled journalists and insightful commentators.

Members of The Currency get full access to over 4,000 exclusive interviews, investigations, and analysis, plus over 460 podcasts.

Annual membership is just €200 for the first year, a saving of €100.

Or try The Currency for the first month for a special introductory rate of €5, a saving of €20.

Cancel at any time.

To become a member today click here.